Patient perspectives on involvement in cancer research in the UK

European Journal of Cancer Care

Volumn 11, Issue 3, 2002, Pages 205-209

  Thornton, Hazel ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Citizens; Information provision; Patient involvement; Processes and systems; Stakeholders

Indexed keywords

ARTICLE; HEALTH CARE QUALITY; HUMAN; HUMAN EXPERIMENT; INFORMATION PROCESSING; METHODOLOGY; NEOPLASM; PATIENT PARTICIPATION; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RESEARCH; STATISTICS; UNITED KINGDOM;

DATA COLLECTION; GREAT BRITAIN; HUMAN EXPERIMENTATION; HUMANS; NEOPLASMS; PATIENT PARTICIPATION; QUALITY OF HEALTH CARE; QUESTIONNAIRES; RESEARCH;

EID: 1842833724     PISSN: 09615423     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2354.2002.00340.x     Document Type: Article

References (33)

1. Anon. (2002) The globalisation of the NHS [Editorial]. Lancet 359, 1447-1448.
2. Baum M. & Thornton H. (2001) Invited joint paper: 'Women's Advocacy Groups and Research in Breast Cancer'. The Breast 10 (Suppl. 3), 19-22.
3. Calman K. & Hine D. (1994) Consultative document. A policy framework for commissioning cancer services. Prepared by an Expert Advisory Group on Cancer to The Chief Medical Officers of England and Wales.
4. Charnock D. (1998) The DISCERN Handbook: Quality Criteria for Consumer Health Information on Treatment Choices (User Guide and Training Resource). Radcliffe Medical Press, Oxford.
5. Department of Health (2001) A New Approach to Chronic Disease Management for the 21st Century. (http://www.doh.gov.uk/index.html)
6. Doyal L. & Tobias J. (2001) Informed Consent in Medical Research. BMJ Books, London.
7. Duman M. & Farrell C. (2000) The Practicalities of Producing Patient Information - the POPPI guide. BMJ, King's Fund, London.
8. Fallowfield L. (2001) Participation of patients in decision about treatment for cancer. British Medical Journal 323, 1144.
9. Hanley B., Truesdale A., King A. et al. (2001) Involving consumers in designing, conducting and interpreting randomised controlled trials: questionnaire survey. British Medical Journal 322, 519-523.
10. Jenkins V. & Fallowfield L. (2000) Reasons for accepting or declining to participate in randomised clinical trials for cancer therapy. British Journal of Cancer 82, 1783-1788.
11. Last M. (2000) High quality matters. Issue 8, Winter 2000, pp. 4-5, Centre for Health Information Quality, Winchester.
12. Lees N., Dixon-Woods M., Young B., Heney D. & Thornton H. (2001) CaTLET: evaluation of information leaflets for patients entering cancer trials. Psycho-Oncology 10, 266-266.
13. Lynda Jackson Macmillan Centre for Cancer Support and Information (1998) Breast Cancer Hormones and HRT. Lynda Jackson Macmillan Centre, Mount Vernon Hospital, Northwood, Middlesex.
14. Marsden J., Sacks N., Whitehead M.I. & Crook D. (1995) Protocol for randomised clinical trial of hormone replacement therapy (HRT) in symptomatic patients with previous breast cancer a feasibility study, Royal Marsden Hospital protocol.
15. Medical Professionalism Project (2002) Medical professionalism in the new millennium: a physicians' charter. Lancet 359, 520-522.
16. Morgan D.L. (1988) Focus Groups as Qualitative Research, Vol. 16, monograph Series Qualitative Research Methods. Sage Publications, London.
17. MRC HSRC (2001) Trial Managers' Network Trial Management Guide, 2nd edn, p. 18. MRC HSRC, Aberdeen.
18. NHS Breast Screening Programme (1989) Protocol of the UK Randomised Trial for the Management of Screen-Detected Ductal Carcinoma in Situ (DCIS) of the Breast. UKCCCR.
19. NHS R&D Cancer Programme (1995-96) Project NCP/D18: using a consumers advisory group to increase accrual into trials. 1995 Project Document.
20. Radiotherapy Action Group Exposure (RAGE) (1995) Health Committee Third Report. Breast Cancer Services 11, 197-198.
21. Refractor (2002) Cancer: care or cure? The Lancet 359, 984.
22. Royle J., Steel R., Hanley B. et al. (2001) Getting involved in research: a guide for consumers. Vignette, p. 25. Consumers in NHS Research Support Unit, Winchester.
23. Sleath B. & Rucker D.R. (2001) Consumer participation in health policy decisions: empowerment or puffery? Journal of Health Care for the Poor and Underserved 12, 1.
24. Thornton H.M. (1992) Breast cancer trials: a patient's viewpoint. Lancet 339, 44-45.
25. Thornton H. (1997) Randomised clinical trials: the patient's point of view. In: Ductal Carcinoma in Situ of the Breast (ed. Silverstein M.), with commentary by David K. Wellisch. Williams & Wilkins, Philadelphia.
26. Thornton H. (1998a) Ought the impact of different types of consumer involvement in various research activities (commissioning, trial protocol planning, Cochrane Reviews, etc) be evaluated? (Abstract) European Journal of Cancer 34 (Suppl. 1), S15.
27. Thornton H. (1998b) Economy, equity, efficiency, effectiveness: the NHS breast screening programme from a patient's perspective. Clinician in Management 7, 112-116.
28. Thornton H. (1999) Today's patient: passive or involved? The Lancet 354 (Suppl.), 48.
29. Thornton H. (2000) What can patients contribute to the design of clinical trials? In: Breast Cancer: New Horizons in Research and Treatment (eds Tobias J., Houghton J. & Craig Henderson I.). Arnold, London.
30. Thornton H. (2002) Empowering' patient choice about participation in trials? In: Clinical Trials (eds Duley L. & Farrell B.), p. 122. BMJ Books, London.
31. UK HRT Trial (2001) Randomised Trial of Hormone Replacement Therapy (HRT) in Women With a History of Early Stage Breast Cancer. CRC/Consortium of Pharmaceutical companies, Institute of Cancer Research, Sutton, Surrey.
32. UK Parliamentary Health Committee (1995) Third Report: Breast Cancer Services, Vol. II. HMSO, London.
33. Wager E., Tooley J.H., Emanuel M.B. et al. (1995) Get patients' consent to enter clinical trials. British Medical Journal 311, 734-737.